Latest Articlesddd
Cassava Sciences Study Results of Sumifilam for Alzheimer's Disease Prohost is happy to inform our subscribers …
Gilead Sciences News Is Not Just Gossip Real news, not just gossip, is spreading today about …
Why Agenus Stock Rallied Yesterday On September 2, 2020 we posted an article about Agenus (AGEN) …
Inovio COVID-19 Vaccine Candidate Will be Manufactured by Thermo Fisher Scientific Thermo Fisher Scientific (TMO) joins …
Compugen Announced Encouraging News from Its Phase 1/2 Study of COM701 Compugen (CGEN) announced that the …
Sanofi and GlaxoSmithKline Have COVID-19 Vaccines Advancing in Clinical Trial Sanofi (SNY) and GlaxoSmithKline (GSK) started …
CDC Is Asking States to Prepare for COVID-19 Vaccines The U.S. Center of Disease Control and …
Agenus Announced Data from Phase 2 Trials of Balstilimab Agenus (AGEN) immuno-oncology company announced that data …
Moderna Inc Late August Announcements On August 28, 2020 Moderna Inc (MRNA) issued a press release …
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals (RYTM) is a late-stage biopharmaceutical company with a product pipeline that …
Moderna Presented Interim Clinical Data about mRNA-1273 for COVID-19 Moderna (MRNA) presented new Interim Clinical Data …
Exelixis Announces Submission of sNDA to US FDA for CABOMETYX® Exelixis (EXEL) announced the submission of …
The US FDA Awards Fast Track Designation to Paxalisib for Glioblastoma Kazia Therapeutics Ltd (KZIA) – an …
Recent Gene Therapy News On August 20, 2020 Audentes Therapeutics, which was taken over by Astellas …
Yesterday, under Today’s Highlights, we posted that the U.S. FDA issued a Complete Response Letter (CRL) …
Gilead Sciences Was Issued a CLR from the FDA for Filgotinib Gilead Sciences (GILD) is in …
CureVac is Publicy Trading on the NASDAQ CureVac is now publicly trading on the NASDAQ stock …
Sorrento Therapeutics Announcement Sorrento Therapeutics (SRNE) announced that it believes it has uncovered fraudulent attempts to …
A Predictive COVID-19 Test? COVID-19 infected people are not all affected to the same degree with …
Intellia Therapeutics Reporting operational highlights and financial results for the second quarter ended June 30, 2020, Intellia …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
